Literature DB >> 31450511

Diagnostic Potential of Multimodal MRI Markers in Atypical Parkinsonian Disorders.

Morinobu Seki1,2, Klaus Seppi1,2, Christoph Mueller1, Thomas Potrusil1,2, Georg Goebel3, Eva Reiter1, Michael Nocker1, Christian Kremser2,4, Matthias Wildauer2,4, Michael Schocke4, Elke R Gizewski2,4, Gregor K Wenning1, Werner Poewe1, Christoph Scherfler1,2.   

Abstract

BACKGROUND: The diagnostic potential of multimodal MRI approaches to discriminate among progressive supranuclear palsy (PSP), Parkinson variant of multiple system atrophy (MSA-P) and Parkinson's disease (PD) has not been well investigated.
OBJECTIVE: To identify disease-specific neurodegenerative patterns and evaluate the diagnostic accuracy of dedicated MRI, iron concentration (R2*), microstructural integrity (mean diffusivity; MD and fractional anisotropy; FA) as well as volumes were analyzed in patients with PSP, MSA-P and PD.
METHODS: 3T MRI of 18 PSP and 16 MSA-P patients were compared with 16 PD patients matched for age and disease duration as well as 21 healthy controls. Statistical parametric mapping (SPM) was applied to objectively identify focal MRI changes throughout the whole-brain. Following dimensionality reduction of significant and multiple comparison-corrected SPM clusters through principal component analysis (PCA), stepwise receiver-operating characteristic curve analysis (ROC) was applied to determine the diagnostic potential of multimodal MRI parameters.
RESULTS: PCA revealed two components involving multiple regions identified from SPM analysis. The first component was primarily composed of the mean MD value of the thalamus and the mean MD and FA values of the dentatorubrothalamic tract and the corpus callosum. The second component mainly consisted of mean MD and FA values of the middle cerebellar peduncle. ROC analysis showed 92% of PSP patients were differentiated correctly from MSA-P and PD and 80% of MSA-P patients could be distinguished from PD.
CONCLUSION: Multimodal MRI improved the detection of disease-specific neurodegenerative patterns in PSP and MSA-P and highlights its potential to improve the diagnostic accuracy of atypical parkinsonian disorders.

Entities:  

Keywords:  Multimodal MRI; R2*; diffusion tensor zzm321990imaging; multiple system atrophy; principal component analysis; progressive supranuclear palsy

Year:  2019        PMID: 31450511     DOI: 10.3233/JPD-181568

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.568


  4 in total

Review 1.  Multiple system atrophy.

Authors:  Werner Poewe; Iva Stankovic; Glenda Halliday; Wassilios G Meissner; Gregor K Wenning; Maria Teresa Pellecchia; Klaus Seppi; Jose-Alberto Palma; Horacio Kaufmann
Journal:  Nat Rev Dis Primers       Date:  2022-08-25       Impact factor: 65.038

2.  Iron Content in Deep Gray Matter as a Function of Age Using Quantitative Susceptibility Mapping: A Multicenter Study.

Authors:  Yan Li; Sean K Sethi; Chunyan Zhang; Yanwei Miao; Kiran Kumar Yerramsetty; Vinay Kumar Palutla; Sara Gharabaghi; Chengyan Wang; Naying He; Jingliang Cheng; Fuhua Yan; Ewart Mark Haacke
Journal:  Front Neurosci       Date:  2021-01-06       Impact factor: 4.677

3.  Insulin-like growth factor 2 and autophagy gene expression alteration arise as potential biomarkers in Parkinson's disease.

Authors:  Denisse Sepúlveda; Felipe Grunenwald; Alvaro Vidal; Paulina Troncoso-Escudero; Marisol Cisternas-Olmedo; Roque Villagra; Pedro Vergara; Carlos Aguilera; Melissa Nassif; Rene L Vidal
Journal:  Sci Rep       Date:  2022-02-07       Impact factor: 4.379

4.  The Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System Atrophy.

Authors:  David I Finkelstein; Jay J Shukla; Robert A Cherny; Jessica L Billings; Eiman Saleh; Nadia Stefanova; Kevin J Barnham; Paul A Adlard
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.